Cross-Protection Induced by Highly Conserved Human B, CD4+, and CD8+ T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern
S. F. Prakash, N. R. Dhanushkodi, L. Zayou, I. C. Ibraim, A. Quadiri, P. G. Coulon, D. F. Tifrea, B. Suzler, M. Amin, A. Chilukuri, R. A. Edwards, H. Vahed, A. B. Nesburn, B. D. Kuppermann, J. B. Ulmer, , L. BenMohamed
This paper describes a multi-epitope vaccine that provides cross-protection against multiple SARS-CoV-2 variants by inducing functional T cell responses.
Frontiers in Immunology · Jan 22, 2024Peer-reviewedImmunology